Brain metastases risk study for lung cancer patients
Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.
This study uses advanced computer models to predict how likely lung cancer is to spread to the brain and how it may affect your health. It includes people with lung cancer who are getting standard treatment and have had recent MRI and CT scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have lung cancer confirmed by biopsy or other tests.
- You must be able to perform daily activities on your own (KPS score of 70 or higher).
- You must be receiving the standard treatment for your stage of lung cancer (such as surgery, radiation, chemotherapy, or targeted therapy).
- You must have had a brain MRI and chest CT with contrast before starting treatment.
- You cannot have other active cancers (except early skin cancer or a certain type of cervical cancer that has been cured for more than 5 years).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often brain metastasis happens in people with non-small cell lung cancer and how it affects their outlook. By following participants who receive standard treatment, researchers hope to learn more about the risks and outcome.
This trial uses brain MRI scans and deep learning to predict whether non-small cell lung cancer that has spread to the brain has certain gene changes (EGFR or ALK). Knowing this may help guide treatment without needing additional tissue testing.
This trial tests whether doing scheduled brain MRI scans can lower the chance that lung cancer later causes symptomatic brain metastases (tumors that cause symptoms in the brain). If you’re eligible, you’ll get brain MRI surveillance at a specific time after starting radiation.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
This study looks at whether routine brain scans can help manage breast cancer that has spread to other parts of the body. It aims to find brain metastases early in people with certain types of high-risk breast cancer, even before symptoms appear.
This study uses artificial intelligence (AI) to read ultrasound images and predict pressure inside the skull and overall outlook for people with lung cancer that has spread to the lining of the brain. If you have non-small cell lung cancer and leptomeningeal metastases, the trial aims to find better ways to monitor your condition without repeat spinal taps.
Hear when a new AI (Artificial Intelligence) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.